Hade, Istikrar M., et al. “A Repurposed Drug Combination Overcomes Paclitaxel Resistance and Minimizes Toxicity via Dual Metabolic and PH Modulation in Breast Cancer”. Asian Pacific Journal of Cancer Biology, vol. 11, no. 4, Oct. 2026, pp. 1043-61, doi:10.31557/APJCB.2026.11.4.1043.